MedTrace Logo

Emotions Immunology and Breast Cancer

NCT03609671 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2019-08-28

No results posted yet for this study

Summary

Pilot study representing a proof of concept regarding the potential for immune system enhancement with psychotherapy, resulting in improved immunological response at lumpectomy or mastectomy in patients undergoing neoadjuvant chemotherapy.

Conditions

Interventions

BEHAVIORAL

Standard of Care + Experimental Individualized Therapy

Participants will receive standard of care plus supportive psychotherapy for a one hour, weekly, during the time they are undergoing neoadjuvant treatments.

OTHER

Control: Standard of Care

Participants will undergo standard of care only (no Intervention/no individualized therapy) .

Sponsors & Collaborators

  • Luz A. Venta, MD

    lead OTHER

Principal Investigators

  • Luz A. Venta, MD · The Methodist Hospital Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-23
Primary Completion
2019-03-18
Completion
2019-03-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03609671 on ClinicalTrials.gov